{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:52:16Z","timestamp":1764510736242},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00277-020-04371-1","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:01:32Z","timestamp":1610553692000},"page":"735-741","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Utilization of radiation therapy in multiple myeloma: trends and changes in practice"],"prefix":"10.1007","volume":"100","author":[{"given":"Sikander","family":"Ailawadhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghna","family":"Ailawadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahara","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prachi","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mays","family":"Abdulazeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chander Shekher","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonikpreet","family":"Aulakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria R.","family":"Alegria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneel","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Chanan-Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimur","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"4371_CR1","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC (2017) Multiple myeloma. Nat Rev Dis Primers 3:17046","journal-title":"Nat Rev Dis Primers"},{"key":"4371_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","volume":"11","author":"J Caers","year":"2018","unstructured":"Caers J, Paiva B, Zamagni E, Leleu X, Blad\u00e9 J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosi\u00f1ol L (2018) Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol 11:10","journal-title":"J Hematol Oncol"},{"key":"4371_CR3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/JCO.18.02096","volume":"37","author":"J Mikhael","year":"2019","unstructured":"Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, Lacy M, Lipe B, Little RF, Nikonova A, Omel J, Peswani N, Prica A, Raje N, Seth R, Vesole DH, Walker I, Whitley A, Wildes TM, Wong SW, Martin T (2019) Treatment of multiple myeloma: ASCO and CCO Joint Clinical Practice Guideline. J Clin Oncol 37:1228\u20131263","journal-title":"J Clin Oncol"},{"key":"4371_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fonc.2015.00040","volume":"5","author":"G Talamo","year":"2015","unstructured":"Talamo G, Dimaio C, Abbi KK et al (2015) Current role of radiation therapy for multiple myeloma. Front Oncol 5:40","journal-title":"Front Oncol"},{"key":"4371_CR5","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111:2516\u20132520","journal-title":"Blood"},{"key":"4371_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122\u20131128","journal-title":"Leukemia"},{"key":"4371_CR7","unstructured":"NCCN Guidelines Version 2.2020 Multiple Myeloma, (ed 10\/9\/2019), National Comprehensive Cancer Network, 2020"},{"key":"4371_CR8","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1200\/JOP.19.00309","volume":"16","author":"V Kumar","year":"2020","unstructured":"Kumar V, Alhaj-Moustafa M, Bojanini L, Sher T, Roy V, Manochakian R, Vishnu P, Bodepudi S, Shareef Z, Ahmed S, Jani P, Paulus A, Grover A, Alegria VR, Ailawadhi M, Chanan-Khan A, Ailawadhi S (2020) Timeliness of initial therapy in multiple myeloma: trends and factors affecting patient care. JCO Oncol Pract 16:e341\u2013e349","journal-title":"JCO Oncol Pract"},{"key":"4371_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Stewart AK, Winchester DP, Ko CY (2008) The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15:683\u2013690","journal-title":"Ann Surg Oncol"},{"key":"4371_CR10","first-page":"101","volume":"14","author":"K Hu","year":"2000","unstructured":"Hu K, Yahalom J (2000) Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park) 14:101\u2013108, 111; discussion 111\u20132, 115","journal-title":"Oncology (Williston Park)"},{"key":"4371_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","volume":"101","author":"RW Tsang","year":"2018","unstructured":"Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J (2018) Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 101:794\u2013808","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4371_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13014-015-0374-z","volume":"10","author":"C Matuschek","year":"2015","unstructured":"Matuschek C, Ochtrop TA, Bolke E et al (2015) Effects of radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a single institution. Radiat Oncol 10:71","journal-title":"Radiat Oncol"},{"key":"4371_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.adro.2018.09.009","volume":"4","author":"L Resende Salgado","year":"2019","unstructured":"Resende Salgado L, Wang S, Adler A, Chang S, Ru M, Moshier E, Dharmarajan K, Jay Cho H, Bakst R (2019) The safety profile of concurrent therapy for multiple myeloma in the modern era. Adv Radiat Oncol 4:112\u2013117","journal-title":"Adv Radiat Oncol"},{"key":"4371_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.clml.2014.07.010","volume":"14","author":"SM Shin","year":"2014","unstructured":"Shin SM, Chouake RJ, Sanfilippo NJ, Rapp TB, Cook P, Formenti SC, Mazumder A, Silverman JS (2014) Feasibility and efficacy of local radiotherapy with concurrent novel agents in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk 14:480\u2013484","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4371_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","volume":"144","author":"GM Dores","year":"2009","unstructured":"Dores GM, Landgren O, McGlynn KA et al (2009) Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 144:86\u201394","journal-title":"Br J Haematol"},{"key":"4371_CR16","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BGM, Miguel JFS (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548","journal-title":"Lancet Oncol"},{"key":"4371_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000163","volume":"3","author":"MV Mateos","year":"2019","unstructured":"Mateos MV, Ludwig H, Bazarbachi A, Beksac M, Blad\u00e9 J, Boccadoro M, Cavo M, Delforge M, Dimopoulos MA, Facon T, Geraldes C, Goldschmidt H, H\u00e1jek R, Hansson M, Jamroziak K, Leiba M, Masszi T, Mendeleeva L, O\u2019Dwyer M, Plesner T, San-Miguel JF, Straka C, van de Donk NWCJ, Yong K, Zver S, Moreau P, Sonneveld P (2019) Insights on multiple myeloma treatment strategies. Hemasphere 3:e163","journal-title":"Hemasphere"},{"key":"4371_CR18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/cncr.31237","volume":"124","author":"S Ailawadhi","year":"2018","unstructured":"Ailawadhi S, Frank RD, Sharma M, Menghani R, Temkit M\u2019, Paulus S, Khera N, Hashmi S, Advani P, Swaika A, Paulus A, Aslam N, Sher T, Roy V, Colon-Otero G, Chanan-Khan A (2018) Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities. Cancer 124:1710\u20131721","journal-title":"Cancer"},{"key":"4371_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11899-016-0323-4","volume":"11","author":"C Pawlyn","year":"2016","unstructured":"Pawlyn C, Gay F, Larocca A, Roy V, Ailawadhi S (2016) Nuances in the management of older people with multiple myeloma. Curr Hematol Malig Rep 11:241\u2013251","journal-title":"Curr Hematol Malig Rep"},{"key":"4371_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.6004\/jnccn.2014.0055","volume":"12","author":"NS Raje","year":"2014","unstructured":"Raje NS, Yee AJ, Roodman GD (2014) Advances in supportive care for multiple myeloma. J Natl Compr Cancer Netw 12:502\u2013511","journal-title":"J Natl Compr Cancer Netw"},{"key":"4371_CR21","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","volume":"3","author":"S Ailawadhi","year":"2019","unstructured":"Ailawadhi S, Parikh K, Abouzaid S, Zhou Z, Tang W, Clancy Z, Cheung C, Zhou ZY, Xie J (2019) Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv 3:2986\u20132994","journal-title":"Blood Adv"},{"key":"4371_CR22","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/cam4.1246","volume":"6","author":"S Ailawadhi","year":"2017","unstructured":"Ailawadhi S, Frank RD, Advani P, Swaika A, Temkit M\u2019, Menghani R, Sharma M, Meghji Z, Paulus S, Khera N, Hashmi SK, Paulus A, Kakar TS, Hodge DO, Colibaseanu DT, Vizzini MR, Roy V, Colon-Otero G, Chanan-Khan AA (2017) Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-Medicare analysis. Cancer Med 6:2876\u20132885","journal-title":"Cancer Med"},{"key":"4371_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"4371_CR24","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1002\/cncr.25297","volume":"116","author":"TV Joshua","year":"2010","unstructured":"Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM (2010) Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer 116:3469\u20133476","journal-title":"Cancer"},{"key":"4371_CR25","doi-asserted-by":"publisher","first-page":"895765","DOI":"10.1100\/2012\/895765","volume":"2012","author":"S Kilciksiz","year":"2012","unstructured":"Kilciksiz S, Karakoyun-Celik O, Agaoglu FY et al (2012) A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. ScientificWorldJournal 2012:895765","journal-title":"ScientificWorldJournal"},{"key":"4371_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/EDBK_238551","volume":"39","author":"S Ganguly","year":"2019","unstructured":"Ganguly S, Mailankody S, Ailawadhi S (2019) Many shades of disparities in myeloma care. Am Soc Clin Oncol Educ Book 39:519\u2013529","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04371-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-04371-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04371-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:22:55Z","timestamp":1614421375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-04371-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4371"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04371-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable, the study was IRB exempt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable. No informed consent was obtained as anonymized aggregate data was obtained from NCDB as per their guidelines and application process (ExternalRef removed).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}